This inventor holds 5 USPTO granted patents and 21 published patent applications, plus 2 CIPO patents and 3 EPO patents. Top assignee: Abbvie Inc.. Active years: 2016-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016-2018
Title: Innovator Spotlight: Steven D Fidanze - Pioneering Inventor in Pharmaceuticals
Introduction:
Steven D Fidanze, a distinguished inventor based in Grayslake, IL, has made significant contributions to the field of pharmaceuticals. With a total of 5 patents under his name, his innovative work has paved the way for advancements in the treatment of various diseases and conditions, including inflammatory diseases, cancer, and AIDS.
Latest Patents:
One of Steven D Fidanze's latest patents involves Bromodomain inhibitors, introducing compounds of formula (I) that have shown promising results as agents for treating a range of diseases. Additionally, his work on Substituted 1,4,10-triazadibenzo[cd,f]azulenes and related compounds as bromodomain inhibitors highlights his commitment to developing novel pharmaceutical solutions for complex medical challenges.
Career Highlights:
Currently affiliated with AbbVie Inc., a renowned pharmaceutical company, Steven D Fidanze continues to drive innovation and research in the industry. His expertise and dedication have led to the successful filing of multiple patents, solidifying his reputation as a leading figure in pharmaceutical innovation.
Collaborations:
Collaboration plays a crucial role in the world of invention, and Steven D Fidanze has had the privilege of working alongside talented individuals in his field. Notable coworkers include Keith F McDaniel and George S Sheppard, who have contributed to the collective efforts aimed at advancing pharmaceutical research and development.
Conclusion:
In conclusion, Steven D Fidanze's groundbreaking work in the realm of pharmaceutical inventions has significantly impacted the healthcare landscape. His patents stand as a testament to his creativity, expertise, and commitment to improving treatments for various diseases. As he continues to push the boundaries of innovation, the future holds promising prospects for further advancements in the field of pharmaceuticals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile